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Abstract ：Objective ：Applying 1H nuclear magnetic resonance（1H-NMR）based metabonomics 
to study the changes of small molecular metabolites in the urine of the model rats of Wilson's disease. 
To explore the pathogenesis of Wilson's disease in small molecular aspect. Methods ：28 male Wistar 
rats[weight=(180±20) g] were divided into two groups randomly，the model group（n=14）and the control 
group（n=14），with the models established by copper-loaded method. Urine of the rats was tested with 
1H-NMR technology. The spectra was edited with MestRe-C2.3 and self-programmed software and 
then principal component analysis（PCA）was applied to differentiate the two groups. Results ：Acetate 
concentration was found to be significantly higher in the urine of the model group ；citrate，PAG，succinate，
methylamine，creatine/creatinine，pyruvate，DMG，and alanine were higher，and choline and taurine were 
lower in the urine of the model group. The small molecular metabolites mentioned above may contribute to 
the discrimination of the two groups，and provide references for further researches on the pathogenesis of 
WD.































































250 μL缓 冲 液（0.2 mol/L Na2HPO4/NaH2PO4，
pH=7.4，D2O，99.9% D），并加入适量的DSS作为
化学位移定标物，配好后移入5 mm样品管中，在










铜含量 对照组平均值 WD 模型组
尿铜含量（μg/24 h） 36.9±6.7 156.8±34.0*
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Clinical Research of Shuangbai Powder of Different Excipients Modulation 
by External Application in Treatment of Acute Cholecystitis 
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University of Chinese Medicine，Guangzhou 510405，Guangdong，China）
Abstract ：Objective ：To observe the clinical efficacy of Shuangbai Powder by external application for 
the patients with acute cholecystitis，and to determine the clinical efficacy of the different modulations of the 
excipients，screening the best excipient for Shuangbai Powder external application. Methods ：This research 
was a prospective clinical study on the 250 patients with acute cholecystitis which were analysed by per-
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